Sondermann, Marcus http://orcid.org/0000-0002-4629-0707
Menzel, Viktoria
Borkowetz, Angelika
Baunacke, Martin
Huber, Johannes
Eisenmenger, Nicole
Thomas, Christian
Boehm, Katharina
Funding for this research was provided by:
Technische Universität Dresden
Article History
Received: 2 February 2024
Accepted: 29 May 2024
First Online: 25 June 2024
Declarations
:
: Mrs. Eisenmenger is founder and director of RI Innovation GmbH. J. Huber is Medical Board member of the “Urologische Stiftung Gesundheit gGmbH,” Chairman of the Working Group “Health Services Research, Quality and Economics” of the German Society of Urology e. V. and initiator of the “Entscheidungshilfe Prostatakrebs” (). The latter is supported by Takeda Pharma, Janssen Cilag GmbH and APOGEPHA. He further indicates support of scientifc projects outside the submitted work by Intuitive Surgical and Coloplast. All the other authors have no conficts of interest to declare.